The nature of the alpha-methyldopa red-cell antibody

The New England Journal of Medicine
A F LoBuglio, J H Jandl


No abstract listed.


Jan 27, 1966·The New England Journal of Medicine·L D Petz, H H Fudenberg
May 1, 1956·The American Journal of Medicine·A L FREEDMANE A BRODY
Jul 1, 1957·British Journal of Haematology·W WEINER
May 9, 1958·Science·A B LEYA CAHAN
Jan 1, 1960·Archives of Internal Medicine·N GREEN, H GOLDENBERG
Apr 1, 1963·Annals of Internal Medicine·J H JANDL
Sep 1, 1963·The Biochemical Journal·N C HUGHES-JONESR TELFORD
Nov 1, 1963·Annals of the Rheumatic Diseases·H O NIEWEGA JANSZ
Sep 1, 1964·Vox Sanguinis·J DAUSSET, L CONTU
Jul 1, 1965·British Journal of Haematology·W J JENKINSR L CARTER
Jul 1, 1965·The Journal of Clinical Investigation·H S JACOBJ H JANDL

❮ Previous
Next ❯


Mar 29, 2002·American Journal of Hematology·Bradley C Gehrs, Richard C Friedberg
Nov 1, 1994·Annals of Hematology·J E Baier, D Poehlau
Jan 1, 1986·Veterinary Research Communications·P J Handagama, B F Feldman
Jan 1, 1992·Pharmacology & Therapeutics·G D Johnston
Jul 20, 1967·The New England Journal of Medicine
Oct 22, 1970·The New England Journal of Medicine·G L LogueW F Rosse
Jun 29, 1972·The New England Journal of Medicine·C Joseph
Apr 10, 1980·The New England Journal of Medicine·H H KirtlandD A Horwitz
Jan 1, 1969·British Journal of Haematology·S M Worlledge
Jan 1, 1969·British Journal of Haematology·G N VyasL D Petz
Apr 1, 1971·Vox Sanguinis·R E HenryR D Ansel
Aug 31, 1968·British Medical Journal·G L ScottP A Bacon
Jan 1, 1968·Postgraduate Medical Journal·M Hamilton
Jun 1, 1968·Postgraduate Medical Journal·I SurveyorT E Parry
Nov 1, 1969·The Journal of Clinical Investigation·L D PetzJ Müller-Eberhard
Apr 1, 1975·The Journal of Clinical Investigation·S P Masouredis, E Sudora
Oct 1, 1993·Transfusion Medicine Reviews·N R Shulman, D M Reid
Jan 1, 1971·Biochemical Pharmacology·R J Sassetti, H H Fudenberg
Mar 1, 1988·Blood Reviews·W G Murphy, J G Kelton
Jun 1, 1989·Blood Reviews·S Ammus, A A Yunis
Apr 1, 1975·The American Journal of Medicine·A S Nies
Jul 26, 2005·Seminars in Hematology·Patricia A Arndt, George Garratty
May 1, 1988·Annals of Emergency Medicine·D Egbert, D K Hendricksen
May 4, 2005·The American Journal of Medicine·Naomi KoCharles M Wiener
Mar 1, 1988·Hypertension·K Engelman
Jan 1, 1986·Scandinavian Journal of Haematology·M R KramerC Hershko
Dec 15, 1971·Klinische Wochenschrift·K SchraderD Renner
May 1, 1974·Postgraduate Medicine·N Costea, J Eipe
Jan 1, 1973·Scandinavian Journal of Haematology·E P Gabor, L S Goldberg
May 1, 1974·Anaesthesia and Intensive Care·J D Gillies
Aug 14, 2012·Transfusion·Beate MayerAbdulgabar Salama

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.